Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pre-BTD expectations in August vs October

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Nov 08, 2023 10:02pm

246 Views

Post# 35725210

RE:RE:Pre-BTD expectations in August vs October

Great post Eogan...I fully agree that RDW was simply responding to how the question was asked as per your text (per below). That's what I heard as well

"It was Ms. Robertson who brought up the next 6 to 12 months, not Roger. He merely tried to answer the question in the terms it was being asked."

<< Previous

Bullboard Posts

Next >>

New CEO leads Sonoro Energy's vision to expand in MENA